Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $3.03B | $3.15B | -3.70% |
Operating Income | $591.7M | $751.4M | -21.25% |
Net Income | $808.7M | $722M | +12.01% |
EPS (Basic) | $7.58 | $6.70 | +13.13% |
EPS (Diluted) | $7.27 | $6.27 | +15.95% |
R&D Expense | $1.33B | $1.25B | +6.33% |
SG&A Expense | $633M | $689M | -8.13% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $37.55B | $34.37B | +9.24% |
Current Assets | $17.57B | $18.87B | -6.89% |
Total Liabilities | $8.16B | $7.38B | +10.56% |
Current Liabilities | $3.57B | $3.58B | -0.40% |
Stockholders' Equity | $29.39B | $26.99B | +8.88% |
Cash & Equivalents | $3.09B | $2.6B | +18.76% |
Long-Term Debt | $1.98B | $1.98B | +0.08% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.05B | $1.51B | -30.90% |
Investing Cash Flow | $647.5M | $-1.69B | +138.38% |
Financing Cash Flow | $-1.09B | $47.1M | -2412.53% |
Dividends Paid | $93.8M | $0 | — |
Share Buybacks | $1.04B | $291.3M | +257.50% |
D&A | $126.9M | $114.1M | +11.22% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 19.5% | 23.9% | -4.36% |
Net Margin | 26.7% | — | — |
ROE | 2.8% | — | — |
ROA | 2.2% | — | — |
Current Ratio | $4.927 | — | — |
Debt to Equity | $0.278 | — | — |
Other companies in Biotechnology